Skip to main content
Premium Trial:

Request an Annual Quote

MolecularWare Embarks on Next Stage of Growth with $2.5M in Funding


While funding may be hard to come by in some high-tech sectors, bioinformatics companies seem to be bucking the economic trend. Last week, MolecularWare of Cambridge, Mass., closed on a $2.5 million first round of financing from several funding sources, led by the Aspen Investment Group and KnowledgeCube Group.

MolecularWare joins Viaken, Inpharmatica, and Scimagix, who secured a total of $82 million in funds during July.

Richard Kivel, CEO of MolecularWare, said the company would put the money toward new hires and continued development of its DigitalGenome data management software. He said the company would also look into building a second suite of software products that will address data mining and storage.

DigitalGenome automatically captures data from various high-throughput instruments, such as liquid handling robots, microarraying robots, and microarray scanners. There are currently three stages to the system: experimental design, analysis, and integration. Kivel said the company is hoping to expand the current functionality of the system based on user feedback. “We have to stay ahead of the curve,” he said. “Some startup is out there trying to build a better product somewhere.”

The company expects to increase its current staff of 10 to 15 through new hires in technology development and sales. Long term, Kivel said, he sees MolecularWare gaining more of an international presence.

MolecularWare’s current customers for DigitalGenome include the Whitehead Institute at MIT, and Riken University for Genome Research and the University of Tsukuba in Japan.

— BT

Filed under

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.